Nurse Practitioner, Family · Troy, AL
NPI
1457741431
Since 2015
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
200 Cherry St
Troy, AL, 36081
Phone (334) 566-6022
Groups this clinician bills Medicare through
Medicare paid, 2024
$3,618
111 services
Medicare patients, 2024
57
Average age 57
Drug cost, 2024
$2.5M
5,485 prescriptions
Company payments, 2025
$2,244
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephanie Reese was code 99213 (office e&m - established), 111 times for 57 patients. In total Stephanie Reese billed 111 services in 1 codes, and Medicare paid $3,618.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-01-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 111 | 57 | $32.60 | $3,618 |
By year: 2022 $4,730 for 187 services; 2023 $3,286 for 142 services; 2024 $3,618 for 111 services.
Medicare prescription drug claims, 2024
In 2024, the drug Stephanie Reese prescribed most often to Medicare patients was Quetiapine Fumarate, with 486 prescriptions and refills. In total Stephanie Reese wrote 5,485 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Quetiapine Fumarate Generic | 486 | 582 | 83 | $6,620 |
| Trazodone Hcl Generic | 382 | 507 | 81 | $4,206 |
| Olanzapine Generic | 296 | 342 | 55 | $3,735 |
| Invega Sustenna Paliperidone Palmitate | 294 | 294 | 42 | $907K |
| Buspirone Hcl Generic | 294 | 344 | 63 | $3,128 |
| Benztropine Mesylate Generic | 294 | 345 | 56 | $3,170 |
| Haloperidol Generic | 205 | 227 | 36 | $5,099 |
| Aripiprazole Generic | 162 | 190 | 33 | $13K |
| Haloperidol Decanoate Generic | 136 | 136 | 22 | $7,784 |
| Doxepin Hcl Generic | 131 | 167 | 23 | $3,202 |
| Fluphenazine Decanoate Generic | 131 | 133 | 16 | $12K |
| Hydroxyzine Pamoate Generic | 123 | 153 | 34 | $2,494 |
| Risperidone Generic | 121 | 159 | 29 | $1,356 |
| Bupropion Xl Bupropion Hcl | 119 | 161 | 20 | $1,880 |
| Citalopram Hbr Citalopram Hydrobromide | 118 | 172 | 22 | $725 |
Brand drugs: - claims; generic drugs: 4,663 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephanie Reese $2,244 ($2,244 in general payments such as food, travel and fees) from 11 companies. The largest payer was Alkermes, Inc. with $478.
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. ALKS | 16 | $478 |
| Neurocrine BioSciences, Inc. NBIX | 19 | $415 |
| Vanda Pharmaceuticals Inc. VNDA | 11 | $374 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 15 | $230 |
| E.R. Squibb & Sons, L.L.C. BMY | 11 | $201 |
| Teva Pharmaceuticals USA, Inc. TEVA | 10 | $195 |
| Janssen Pharmaceuticals, Inc JNJ | 10 | $152 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 4 | $86.12 |
| Axsome Therapeutics, Inc. AXSM | 3 | $67.58 |
| Lundbeck LLC | 2 | $30.77 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.